Calendar

Nov
4
Sat
Summit Meeting – Los Angeles, CA @ JW Marriott L.A. LIVE
Nov 4 @ 8:00 am – 10:00 am

THE ADVANCES INITIATIVE: New Advances in Headache Diagnosis and Treatment

Saturday, November 04, 2017

7:30 AM – 8:00 AM Registration/Breakfast
8:00 AM – 10:00 AM Meeting

JW Marriott Los Angeles L.A. LIVE
900 West Olympic Boulevard
Los Angeles, CA, 90015
Meeting Room: Plaza II & III

PROGRAM FEATURES

  • Create your own Personalized Poster
  • Interactive, case-based learning environment
  • iPads provided to enhance learning experience
  • 3D videos and glasses provided for all attendees

FACULTY

Jack D. Schim, MD, FAHS
The Neurology Center of Southern California
Co-director, The Headache Center, Carlsbad
Scripps Memorial Hospital-Encinitas
Assistant Clinical Professor of Neurology UCSD
San Diego, CA

M. Susan Burke, MD, FACP
Clinical Associate Professor of Medicine
Sidney Kimmel Medical College at Thomas Jefferson University
Senior Advisor, Lankenau Medical Associates
Lankenau Medical Center
Wynnewood, Pennsylvania

TARGET AUDIENCE

This activity is intended for neurologists, headache specialists, PCPs, and other HCPs involved in managing patients with headache and migraine issues.

LEARNING OBJECTIVES

After completing the CME activity, learners should be better able to:

  • Discuss the prevalence, pathophysiology, epidemiology, and burden of illness associated with migraine.
  • Describe the diagnostic approach to primary headache disorders, with an emphasis on migraine and cluster headache, including differential diagnosis from other conditions causing headache.
  • Discuss the established acute and preventive therapeutic options for patients with migraine.
  • Describe publicly available safety and efficacy findings from recent clinical trials investigating novel therapies for the management of migraine.

ACCREDITATION STATEMENT

Med Learning Group is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

CREDIT DESIGNATION STATEMENT

Med Learning Group designates this live activity for a maximum of 2.0 AMA Category 1 Credit(s)TM.

Physicians should claim only the credit commensurate with the extent of their participation in the live activity.

NURSING CREDIT INFORMATION

Ultimate Medical Academy/CCM is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation. Awarded 2.00 contact hour(s) of continuing nursing education of RNs and APN

Purpose: This program would be beneficial for nurses involved in the care for patients with headache and migraine issues.

Credits: 2.00 ANCC Contact Hour(s)

ABIM MAINTENANCE OF CERTIFICATION

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 2 Medical Knowledge and Practice Assessment MOC points and patient safety MOC credit in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

Information of physician learners in this activity will be shared with ABIM through PARS.

AAPA CREDIT

This program has been reviewed and is approved for a maximum of 2.00 AAPA Category 1 CME credits by the AAPA Review Panel. PAs should claim only the credit commensurate with the extent of their participation in the activity.

This program was planned in accordance with AAPA CME Standards for Live Programs and for Commercial Support of Live Programs.

AAFP CREDIT

This Live activity, The ADVANCES Initiative: New Advances in Headache Diagnosis and Treatment, from 08/17/2017 – 12/05/2017,has been reviewed and is acceptable for up to 2.00 Elective credit(s) by the American Academy of Family Physicians. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

AOA CREDIT

The American Osteopathic Association (AOA) Council on Continuing Medical Education has approved this activity for 2 AOA Category 2-A credits.

DISCLOSURE POLICY STATEMENT

In accordance with the Accreditation Council for Continuing Medical Education (ACCME) Standards for Commercial Support, educational programs sponsored by Med Learning Group must demonstrate balance, independence, objectivity, and scientific rigor. All faculty, authors, editors, staff, and planning committee members participating in a MLG-sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an educational activity.

DISCLOSURE OF UNLABELED USE

Med Learning Group requires that faculty participating in any CME activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States.

DISCLAIMER

Med Learning Group makes every effort to develop CME activities that are scientifically based. This activity is designed for educational purposes. Participants have a responsibility to utilize this information to enhance their professional development in an effort to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making before applying any information, whether provided here or by others, for any professional use.

For CME questions, please contact Med Learning Group at info@medlearninggroup.com.
Contact this CME provider at Med Learning Group for privacy and confidentiality policy statement information at www.medlearninggroup.com/privacy-policy/

AMERICANS WITH DISABILITIES ACT

Event Staff will be glad to assist you with any special needs (i.e. physical, dietary, etc.) Please contact Med Learning Group prior to the live event at info@medlearninggroup.com

Oct
7
Sun
Summit Meeting – San Diego, CA @ Marriott Marquis San Diego Marina
Oct 7 @ 6:00 pm – 7:45 pm

A 3D View: Improving Acute Preventive Treatment of Migraine in Primary Care Setting Using Novel Agents

Sunday, October 07, 2018

6:00 PM – 6:30 PM Registration/Dinner
6:30 PM – 7:45 PM Meeting

VENUE

Marriott Marquis San Diego Marina
333 West Harbor Drive
San Diego, CA 92101
Meeting Room: Ballroom 5-9

PROGRAM FEATURES

  • 1.15 CME Credits: A 3D View!
  • 3D Glasses Provided to all attendees
  • Interactive, case-based learning environment
  • Create your own Personalized Poster

REGISTRATION INFORMATION

To register for the live event meeting or simulcast, please visit www.MLG-Migraine.com or call 2017-406-4248.

FACULTY

Anne H. Calhoun, MD, FAHS
Partner/Co-Founder, Carolina Headache Institute
Professor, Department of Anesthesiology
Professor, Department of Psychiatry
University of North Carolina
Chapel Hill, NC

Andrew Charles, MD
Professor of Neurology
Director, UCLA Goldberg Migraine Program
Meyer and Renee Luskin Chair in Migraine and Headache Studies
David Geffen School of Medicine at
University of California,
Los Angeles, LA

AGENDA

I. Migraine: Overview

  • The burden of migraine: epidemiology, disability and quality of life, economic burden
  • Migraine pathophysiology
  • Migraine and other primary headaches: classification and diagnosis
  • Challenges of differential diagnosis

II. The Current Challenges and Needs in Migraine Management

  • Expanding role for primary care providers and doctors of osteopathy
  • Evidence-based approach to acute and preventive treatment of migraine
  • Abortive agents in development: lasmiditan, gepants, new delivery devices for existing agents
  • Migraine prevention: what are the current unmet needs?
  • Patient segmentation: identifying the patients with refractory chronic migraine

Patient video showing the process of differential diagnosis – leading in to treatment

III. Targeting CGRP or Its Receptor: A New Era in Targeting Migraine Underlying Pathology

  • Role of CGRP in the trigeminovascular system and in migraine
    • Mechanism of action of gepants and mAbs to CGRP or its receptor
  • Update of recently released data from clinical trials
  • Safety
  • Patient-reported outcomes
  • Adherence, persistence and cost-effectiveness, impact on access
  • Interactive case studies, including refractory chronic migraine cases

IV. Neuromodulation: A Brief Update

V. Clinician-patient Communication: Case-based Discussion

  • Improving patient/physician and physician/physician communication

VI. “Conclusions and Questions & Answers

EDUCATIONAL OBJECTIVES

  • Review best practices for diagnosing migraine headaches including the process of differential diagnosis
  • Assess efficacy and safety profiles of investigational agents for the acute treatment of migraine, as well as calcitonin-gene related peptide (CGRP)-targeting agents for the prevention of episodic and chronic migraine
  • Describe burdens associated with migraine headaches and the use of patient reported outcomes for measuring the impact of new and established migraine therapies
  • Discuss strategies for managing migraine that include the integration of novel treatment options and the application of methods for

TARGET AUDIENCE

This activity is intended for primary care providers and doctors of osteopathy working with patients with migraine headaches.

ACCREDITATION STATEMENT

Med Learning Group is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. This CME activity was planned and produced in accordance with the ACCME Essentials.

CREDIT DESIGNATION STATEMENT

Med Learning Group designates this live activity for a maximum of 1.15 AMA Category 1 CreditTM. Physicians should claim only the credit commensurate with the extent of their participation in the live activity.

NURSING CREDIT INFORMATION

Purpose: This program would be beneficial for nurses involved in treating and managing patients with migraine. CNE Credits: 1.15 ANCC Contact Hours

CNE Accreditation Statement

Ultimate Medical Academy/CCM is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.

ABIM MAINTENANCE OF CERTIFICATION

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.15 MOC in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

AOA CREDIT

Med Learning Group will apply to the American Osteopathic Association (AOA) Council on Continuing Medical Education to approve this symposium for AOA Category 2-A credits.

DISCLOSURE POLICY STATEMENT

In accordance with the Accreditation Council for Continuing Medical Education (ACCME) Standards for Commercial Support, educational programs sponsored by Med Learning Group must demonstrate balance, independence, objectivity, and scientific rigor. All faculty, authors, editors, staff and planning committee members participating in a MLG-sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an educational activity.

DISCLOSURE OF UNLABELED USE

Med Learning Group requires that faculty participating in any CME activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States.

DISCLAIMER

Med Learning Group makes every effort to develop CME activities that are scientifically based. This activity is designed for educational purposes. Participants have a responsibility to utilize this information to enhance their professional development in an effort to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making before applying any information, whether provided here or by others, for any professional use.

For CME questions, please contact Med Learning Group at info@medlearninggroup.com.

Contact this CME provider at Med Learning Group for privacy and confidentiality policy statement information at www.medlearninggroup.com/privacy-policy/

AMERICANS WITH DISABILITIES ACT

Event staff will be glad to assist you with any special needs (eg, physical, dietary, etc.). Please contact Med Learning Group prior to the live event at info@medlearninggroup.com

Feb
6
Wed
Summit Meeting – San Diego, CA @ THE WESTIN SAN DIEGO
Feb 6 @ 5:30 pm – 7:30 pm

A 3D View: Improving Acute Preventive Treatment of Migraine in Primary Care Setting Using Novel Agents

WEDNESDAY, FEBRUARY 6, 2019

5:30 PM – 6:00 PM Registration / Dinner
6:00 PM – 7:30 PM Meeting

VENUE

THE WESTIN SAN DIEGO
400 West Broadway
San Diego, CA 92101
MEETING ROOM: Emerald Ballroom

1.5 CME/CNE Credits: A 3D View!

  • 3D GLASSES PROVIDED TO ALL ATTENDEES

Features:

  • Interactive, case-based learning environment
  • Create your own Personalized Poster
  • iPads provided to enhance learning experience and enable real-time Q&A

REGISTRATION INFORMATION

To register for the live event meeting or simulcast, please visit www.MLG-Migraine.com or call 207-406-4248.

FACULTY

Anne H. Calhoun, MD, FAHS
Partner/Co-Founder, Carolina Headache Institute
Professor, Department of Anesthesiology
Professor, Department of Psychiatry
University of North Carolina
Chapel Hill, NC

Andrew Charles, MD
Professor of Neurology
Director, UCLA Goldberg Migraine Program
Meyer and Renee Luskin Chair in Migraine and Headache Studies
David Geffen School of Medicine at
University of California
Los Angeles, LA

AGENDA

I. Overview of headache disorders

  • The burden of migraine: epidemiology, disability and quality of life, economic burden
  • Migraine and other primary headaches: classification and diagnosis of primary headache disorders
  • Patient video showing the process of differential diagnosis – leading into treatment

II. The current challenges and needs in migraine management

  • Expanding role for primary care providers and doctors of osteopathy
  • Evidence-based approach to acute and preventive treatment of migraine
  • Abortive agents in development: lasmiditan, gepants, new delivery devices for existing agents
  • Migraine prevention: what are the current unmet needs?
  • Improving patient/physician and physician/physician communication

III. Targeting CGRP or its receptor: a new era in targeting migraine underlying pathology

  • Role of CGRP in the trigeminovascular system and in migraine
    • Mechanism of action of gepants and mAbs to CGRP or its receptor
  • Update of recently released data from clinical trials
  • Safety
  • Patient-reported outcomes
  • Interactive case studies, including refractory chronic migraine cases
  • Improving patient/physician and physician/physician communication

IV. Neuromodulation: a brief update

V. Conclusions and Q&A

EDUCATIONAL OBJECTIVES

  • Review best practices for diagnosing migraine headaches including the process of differential diagnosis
  • Assess efficacy and safety profiles of investigational agents for the acute treatment of migraine, as well as calcitonin-gene related peptide (CGRP)-targeting agents for the prevention of episodic and chronic migraine
  • Describe burdens associated with migraine headaches and the use of patient-reported outcomes for measuring the impact of new and established migraine therapies
  • Discuss strategies for managing migraine that include the integration of novel treatment options and the application of methods for overcoming patient- and physician-dependent barriers in clinical practice

TARGET AUDIENCE
This activity is intended for primary care providers and doctors of osteopathy working with patients with migraine headaches.

ACCREDITATION STATEMENT
Med Learning Group is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

This CME activity was planned and produced in accordance with the ACCME Essentials.

CREDIT DESIGNATION STATEMENT
Med Learning Group designates this live activity for a maximum of 1.5 AMA Category 1 CreditTM. Physicians should claim only the credit commensurate with the extent of their participation in the live activity.

NURSING CREDIT INFORMATION
Purpose: This program would be beneficial for nurses involved in treating and managing patients with migraine. CNE Credits: 1.5 ANCC Contact Hours

CNE Accreditation Statement:
Ultimate Medical Academy/CCM is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.

ABIM Maintenance of Certification:
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.5 MOC in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

 AOA Credit:
The AOA Bureau of OMED is accredited by the American Osteopathic Association to provide osteopathic continuing medical education for physicians. The AOA Bureau of OMED, as a co-sponsor with Med Learning Group, designates this live program for a maximum of 1.5 AOA Category 2-A credits and will report CME and specialty credits commensurate with the extent of the physician’s participant in this live activity.

DISCLOSURE POLICY STATEMENT
In accordance with the Accreditation Council for Continuing Medical Education (ACCME) Standards for Commercial Support, educational programs sponsored by Med Learning Group must demonstrate balance, independence, objectivity, and scientific rigor. All faculty, authors, editors, staff and planning committee members participating in a MLG-sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an educational activity.

DISCLOSURE OF UNLABELED USE
Med Learning Group requires that faculty participating in any CME activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States.

DISCLAIMER
Med Learning Group makes every effort to develop CME activities that are scientifically based. This activity is designed for educational purposes. Participants have a responsibility to utilize this information to enhance their professional development in an effort to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making before applying any information, whether provided here or by others, for any professional use.

For CME questions, please contact Med Learning Group at info@medlearninggroup.com.

Contact this CME provider at Med Learning Group for privacy and confidentiality policy statement information at www.medlearninggroup.com/privacy-policy/

AMERICANS WITH DISABILITIES ACT
Event staff will be glad to assist you with any special needs (eg, physical, dietary, etc.). Please contact Med Learning Group prior to the live event at info@medlearninggroup.com